Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.

4012Background: We evaluated use of early PET response after induction chemotherapy (CT) to direct changing to alternative CT during preoperative chemoradiation (CRT) among patients (pts) with rese...